Related Experiment Videos
Somatic genetic changes in human breast cancer
1Department of Pathology, University of Leiden, The Netherlands.
Biochimica Et Biophysica Acta
|December 30, 1994
Summary
Breast tumors exhibit widespread chromosomal imbalances, impacting DNA stemlines and heterozygosity. These genetic changes, while complex and heterogeneous, suggest a potential stage of equilibrium in tumor progression, possibly driven by gene dosage effects.
Area of Science:
- Genetics
- Oncology
- Genomic Instability
Background:
- Quantitative imbalance of chromosomal material is a hallmark genetic alteration in breast tumors.
- This imbalance is evident through deviant DNA stemlines, numerical chromosome abnormalities, and loss of heterozygosity.
- While TP53 and ERBB2 are key genes, the roles of others like MYC and CCND1 are still under investigation.
Purpose of the Study:
- To analyze the quantitative imbalance of chromosomal material in breast tumors.
- To investigate the relationship between chromosomal abnormalities and gene amplification.
- To explore the genetic evolution and heterogeneity in breast tumor development.
Main Methods:
- DNA flow cytometry to analyze deviant DNA stemlines.
- Karyotype analysis for numerical chromosome abnormalities.
- DNA polymorphism studies for loss of heterozygosity (LOH).
Main Results:
- Breast tumors display significant chromosomal imbalances affecting multiple chromosomes.
- Intra- and intertumor heterogeneity in chromosome involvement is observed, suggesting genetic instability.
- Evidence suggests genetic evolution reaches equilibrium in tumor progression, with allelic imbalances potentially driving tumorigenesis via gene dosage effects.
Conclusions:
- Chromosomal imbalances are a primary genetic event in breast cancer.
- Tumor heterogeneity exists, but a stage of genetic equilibrium may be reached during progression.
- Allelic imbalances, potentially causing gene dosage effects, can contribute to tumor growth and selective advantage.